Israel - English - Ministry of Health

padagis israel agencies ltd, israel - levothyroxine sodium - tablets - levothyroxine sodium 100 mcg - levothyroxine sodium - levothyroxine sodium - treatment of hypothyroidism, cretinism and juvenile myxoedema.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; dextrin; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet, uncoated - excipient ingredients: magnesium stearate; dextrin; maize starch; lactose monohydrate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: magnesium stearate; dextrin; lactose monohydrate; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.05 mg - tablet, uncoated - excipient ingredients: dextrin; maize starch; lactose monohydrate; magnesium stearate - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: dextrin; magnesium stearate; lactose monohydrate; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - levothyroxine sodium, quantity: 0.05 mg - tablet, uncoated - excipient ingredients: dextrin; magnesium stearate; lactose monohydrate; maize starch - oroxine is indicated for the management of demonstrated thyroid hormone deficiency.,oroxine is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Malta - English - Medicines Authority

colonis pharma limited quantum house, hobson industrial estate, burnopfield, country, durham ne16 6ea, united kingdom - levothyroxine sodium - oral solution - levothyroxine sodium 100 µg/5ml - thyroid therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; pregelatinised starch; microcrystalline cellulose; allura red ac aluminium lake; indigo carmine aluminium lake - levothyroxine sodium is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sodium is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - levothyroxine sodium, quantity: 0.1 mg - tablet - excipient ingredients: magnesium stearate; hyprolose; pregelatinised starch; microcrystalline cellulose; sunset yellow fcf aluminium lake; quinoline yellow aluminium lake - levothyroxine sodium is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sodium is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.